Repare Therapeutics Inc (RPTX) Stock Analysis

Repare Therapeutics Inc (RPTX) is a publicly traded company in the HEALTHCARE sector. It trades at $2.65. This page summarizes the public market data, fundamentals, and frequently asked questions for RPTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.65

Market Sentiment

Repare Therapeutics Inc currently has a Neutral sentiment score of -0.06.

About Repare Therapeutics Inc

Repare Therapeutics Inc. (RPTX) is a precision oncology company focused on transforming cancer treatment through its pioneering synthetic lethality approach. Headquartered in Montreal, Canada, the company operates in both Canada and the United States, leveraging advanced scientific methodologies to identify and develop innovative therapies that target specific genetic vulnerabilities in tumors. With a strong pipeline of drug candidates, Repare Therapeutics aims to address unmet medical needs ...

GNG Research Analysis

GNG Research scores Repare Therapeutics Inc (RPTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RPTX.

Frequently Asked Questions

Does RPTX pay dividends?

Repare Therapeutics Inc (RPTX) does not currently pay a regular dividend.